Marine actinomycete taxon for drug and fermentation product discovery
US7144723B2 · kind B2 · utility
33Cited by
12References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 16, 2001 |
| Grant date | Dec 5, 2006 |
| Priority date | — |
| Expiry date | Nov 16, 2021 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/36
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention is the discovery of an actinomycete genus, given the name Salinospora gen. nov., that displays an obligate requirement of seawater (Na+) for growth and unique 16S rRNA signature nucleotides. The invention is also the use of the genus for the production and discovery of active biomolecules such as pharmaceutical agents, agrichemicals, immunomodifiers, enzymes and enzyme inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.